Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy

Pharmacology and Therapeutics

Volumn 139, Issue 2, 2013, Pages 289-300

  Loftis, Jennifer M ^a,b,c   Huckans, Marilyn ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Addiction; Drug discovery; Inflammation; Psychoneuroimmunology; Substance use disorders; Treatment strategies

Indexed keywords

ACAMPROSATE; AMPHETAMINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRENORPHINE; CARBAMAZEPINE; CLONIDINE; DISULFIRAM; METHADONE; METHAMPHETAMINE; MINOCYCLINE; MODAFINIL; NALTREXONE; NEUROLEPTIC AGENT; TOPIRAMATE;

ALCOHOL USE DISORDER; ALCOHOL WITHDRAWAL; ALCOHOLISM; COCAINE DEPENDENCE; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNOTHERAPY; NONHUMAN; OPIATE ADDICTION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION; REVIEW; SOCIAL ASPECT; SUBSTANCE ABUSE; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ANIMALS; HUMANS; IMMUNOTHERAPY; SUBSTANCE-RELATED DISORDERS;

EID: 84879420504     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.04.011     Document Type: Review

References (160)

1. R. Ader Much ado about nothing Adv Mind Body Med 17 2001 293 295 (discussion 312-298)
2. S. Alfonso-Loeches, M. Pascual, U. Gomez-Pinedo, M. Pascual-Lucas, J. Renau-Piqueras, and C. Guerri Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse Glia 60 2012 948 964
3. M. Alonso, J. Gomez-Rial, F. Gude, C. Vidal, and A. Gonzalez-Quintela Influence of experimental alcohol administration on serum immunoglobulin levels: contrasting effects on IgE and other immunoglobulin classes Int J Immunopathol Pharmacol 25 2012 645 655
4. P. Anderson Global use of alcohol, drugs and tobacco Drug Alcohol Rev 25 2006 489 502
5. M.C. Andrade, M.J. Albernaz, M.S. Araujo, B.P. Santos, A. Teixeira-Carvalho, and A.M. Faria Short-term administration of ethanol in mice deviates antigen presentation activity towards B cells Scand J Immunol 70 2009 226 237
6. A.M. Arria, R.E. Tarter, and D.H. Van Thiel Vulnerability to alcoholic liver disease Recent Dev Alcohol 9 1991 185 204
7. M. Asanuma, I. Miyazaki, Y. Higashi, T. Tsuji, and N. Ogawa Specific gene expression and possible involvement of inflammation in methamphetamine-induced neurotoxicity Ann N Y Acad Sci 1025 2004 69 75
8. A.H. Avila, C.A. Morgan, and B.M. Bayer Stress-induced suppression of the immune system after withdrawal from chronic cocaine J Pharmacol Exp Ther 305 2003 290 297
9. G.C. Baldwin, D.P. Tashkin, D.M. Buckley, A.N. Park, S.M. Dubinett, and M.D. Roth Marijuana and cocaine impair alveolar macrophage function and cytokine production Am J Respir Crit Care Med 156 1997 1606 1613
10. M.E. Bates, J.F. Buckman, and T.T. Nguyen A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders Neuropsychol Rev 23 2013 27 47
11. B. Beilin, Y. Shavit, E. Trabekin, B. Mordashev, E. Mayburd, and A. Zeidel The effects of postoperative pain management on immune response to surgery Anesth Analg 97 2003 822 827
12. M. Berk, O. Dean, H. Drexhage, J.J. McNeil, S. Moylan, and A. Oneil Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness BMC Med 11 2013 74
13. S.E. Blank, D.A. Duncan, and G.G. Meadows Suppression of natural killer cell activity by ethanol consumption and food restriction Alcohol Clin Exp Res 15 1991 16 22
14. Y.A. Blednov, R.D. Mayfield, J. Belknap, and R.A. Harris Behavioral actions of alcohol: phenotypic relations from multivariate analysis of mutant mouse data Genes Brain Behav 11 2012 424 435
15. Y.A. Blednov, I. Ponomarev, C. Geil, S. Bergeson, G.F. Koob, and R.A. Harris Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies Addict Biol 17 2012 108 120
16. J. Bogdal, K. Cichecka, S. Kirchmayer, M. Mika, and A. Tarnawski Immunoglobulins in chronic alcoholics: relation to liver histology and effect of 2-month abstinence therapy Arch Immunol Ther Exp (Warsz) 24 1976 799 805
17. J.C. Bouchard, J. Kim, D.R. Beal, L.J. Vaickus, F.L. Craciun, and D.G. Remick Acute oral ethanol exposure triggers asthma in cockroach allergen-sensitized mice Am J Pathol 181 2012 845 857
18. F. Bravo, A. Gual, A. Lligoña, and J. Colom Gender differences in the long-term outcome of alcohol dependence treatments: An analysis of twenty-year prospective follow up Drug Alcohol Rev 2012 10.1111/dar.12023 (Epub ahead of print, PubMed PMID: 23240781) (in press)
19. G.R. Breese, D.J. Knapp, D.H. Overstreet, M. Navarro, T.A. Wills, and R.A. Angel Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior Neuropsychopharmacology 33 2008 867 876
20. D. Breitmeier, N. Becker, C. Weilbach, K. Albrecht, D. Scheinichen, and B. Panning Ethanol-induced malfunction of neutrophils respiratory burst on patients suffering from alcohol dependence Alcohol Clin Exp Res 32 2008 1708 1713
21. S.M. Brown, B. Stimmel, R.N. Taub, S. Kochwa, and R.E. Rosenfield Immunologic dysfunction in heroin addicts Arch Intern Med 134 1974 1001 1006
22. J.B. Buchanan, N.L. Sparkman, and R.W. Johnson Methamphetamine sensitization attenuates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus Brain Behav Immun 24 2010 502 511
23. J.B. Buchanan, N.L. Sparkman, and R.W. Johnson A neurotoxic regimen of methamphetamine exacerbates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus J Neuroinflammation 7 2010 82
24. H.M. Buck, C.M. Hueston, C. Bishop, and T. Deak Enhancement of the hypothalamic-pituitary-adrenal axis but not cytokine responses to stress challenges imposed during withdrawal from acute alcohol exposure in Sprague-Dawley rats Psychopharmacology (Berl) 218 1 2011 203 215
25. E.H. Cerny, and T. Cerny Vaccines against nicotine Hum Vaccin 5 2009 200 205
26. L. Chang, C. Cloak, K. Patterson, C. Grob, E.N. Miller, and T. Ernst Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response Biol Psychiatry 57 2005 967 974
27. H. Chen, T. Uz, and H. Manev Minocycline affects cocaine sensitization in mice Neurosci Lett 452 2009 258 261
28. S.L. Chen, P.L. Tao, C.H. Chu, S.H. Chen, H.E. Wu, and L.F. Tseng Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats J Neuroimmune Pharmacol 7 2012 444 453
29. G. Chiva-Blanch, M. Urpi-Sarda, R. Llorach, M. Rotches-Ribalta, M. Guillen, and R. Casas Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial Am J Clin Nutr 95 2012 326 334
30. K.H. Clark, C.A. Wiley, and C.W. Bradberry Psychostimulant abuse and neuroinflammation: Emerging evidence of their interconnection Neurotox Res 23 2 2013 174 188
31. J.K. Coller, and M.R. Hutchinson Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence Pharmacol Ther 134 2012 219 245
32. R.T. Cook Cytoplasmic cytokines in the T cells of chronic alcoholics Alcohol Clin Exp Res 24 2000 241 243
33. M.L. Copersino, D.J. Schretlen, G.M. Fitzmaurice, S.E. Lukas, J. Faberman, and J. Sokoloff Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure Am J Drug Alcohol Abuse 38 2012 246 250
34. F.T. Crews, L. Qin, D. Sheedy, R.P. Vetreno, and J. Zou High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence Biol Psychiatry 73 7 2013 602 612
35. O.M. Dean, J. Data-Franco, F. Giorlando, and M. Berk Minocycline: therapeutic potential in psychiatry CNS Drugs 26 2012 391 401
36. L.A. Dimeff, and M.M. Linehan Dialectical behavior therapy for substance abusers Addict Sci Clin Pract 4 2008 39 47
37. M.J. Dominguez-Santalla, C. Vidal, J. Vinuela, L.F. Perez, and A. Gonzalez-Quintela Increased serum IgE in alcoholics: relationship with Th1/Th2 cytokine production by stimulated blood mononuclear cells Alcohol Clin Exp Res 25 2001 1198 1205
38. R.M. Donahoe, C. Bueso-Ramos, F. Donahoe, J.J. Madden, A. Falek, and J.K. Nicholson Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers Ann N Y Acad Sci 496 1987 711 721
39. T.K. Eisenstein, and M.E. Hilburger Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations J Neuroimmunol 83 1998 36 44
40. H.C. Fox, C. D'Sa, A. Kimmerling, K.M. Siedlarz, K.L. Tuit, and R. Stowe Immune system inflammation in cocaine dependent individuals: implications for medications development Hum Psychopharmacol 27 2012 156 166
41. K. Freeman, A. Brureau, R. Vadigepalli, M.M. Staehle, M.M. Brureau, and G.E. Gonye Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei J Neuroinflammation 9 2012 97
42. Y. Fujita, T. Ishima, S. Kunitachi, H. Hagiwara, L. Zhang, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline Prog Neuropsychopharmacol Biol Psychiatry 32 2008 336 339
43. X. Gan, L. Zhang, T. Newton, S.L. Chang, W. Ling, and V. Kermani Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects Clin Immunol Immunopathol 89 1998 181 190
44. W.B. Gentry, D. Ruedi-Bettschen, and S.M. Owens Development of active and passive human vaccines to treat methamphetamine addiction Hum Vaccin 5 2009 206 213
45. C. Goeldner, P.E. Lutz, E. Darcq, T. Halter, D. Clesse, and A.M. Ouagazzal Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine Biol Psychiatry 69 2011 236 244
46. M.L. Goniewicz, and M. Delijewski Nicotine vaccines to treat tobacco dependence Hum Vaccin Immunother 9 2013 13 25
47. P. Govitrapong, T. Suttitum, N. Kotchabhakdi, and T. Uneklabh Alterations of immune functions in heroin addicts and heroin withdrawal subjects J Pharmacol Exp Ther 286 1998 883 889
48. M.A. Hebert, and J.P. O'Callaghan Protein phosphorylation cascades associated with methamphetamine-induced glial activation Ann N Y Acad Sci 914 2000 238 262
49. T.B. Herbert, and S. Cohen Depression and immunity: a meta-analytic review Psychol Bull 113 1993 472 486
50. J. Hoek, G.M. Thiele, L.W. Klassen, P. Mandrekar, S. Zakhari, and R.T. Cook RSA 2004: combined basic research satellite symposium-mechanisms of alcohol-mediated organ and tissue damage: inflammation and immunity and alcohol and mitochondrial metabolism: at the crossroads of life and death session one: alcohol, cellular and organ damage Alcohol Clin Exp Res 29 2005 1735 1743
51. R.H. Howland Baclofen for the treatment of alcohol dependence J Psychosoc Nurs Ment Health Serv 50 2012 11 14
52. S. Hu, W.S. Sheng, J.R. Lokensgard, and P.K. Peterson Morphine induces apoptosis of human microglia and neurons Neuropharmacology 42 2002 829 836
53. M.R. Irwin, L. Olmos, M. Wang, E.M. Valladares, S.J. Motivala, and T. Fong Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms J Pharmacol Exp Ther 320 2007 507 515
54. P.W. Jareo, L.C. Preheim, and M.J. Gentry Ethanol ingestion impairs neutrophil bactericidal mechanisms against Streptococcus pneumoniae Alcohol Clin Exp Res 20 1996 1646 1652
55. J. Jayaraman, V.A. Jesudoss, V.P. Menon, and N. Namasivayam Anti-inflammatory role of naringenin in rats with ethanol induced liver injury Toxicol Mech Methods 22 2012 568 576
56. T.L. Jernigan, A.C. Gamst, S.L. Archibald, C. Fennema-Notestine, M.R. Mindt, and T.D. Marcotte Effects of methamphetamine dependence and HIV infection on cerebral morphology Am J Psychiatry 162 2005 1461 1472
57. T.R. Jerrells, D. Peritt, C. Marietta, and M.J. Eckardt Mechanisms of suppression of cellular immunity induced by ethanol Alcohol Clin Exp Res 13 1989 490 493
58. B.A. Johnson, N. Ait-Daoud, C.L. Bowden, C.C. DiClemente, J.D. Roache, and K. Lawson Oral topiramate for treatment of alcohol dependence: a randomised controlled trial Lancet 361 2003 1677 1685
59. B.A. Johnson, J.D. Roache, N. Ait-Daoud, L.T. Wells, C.L. Wallace, and M.A. Dawes Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals Prog Neuropsychopharmacol Biol Psychiatry 31 2007 123 130
60. B.A. Johnson, N. Rosenthal, J.A. Capece, F. Wiegand, L. Mao, and K. Beyers Topiramate for treating alcohol dependence: a randomized controlled trial JAMA 298 2007 1641 1651
61. E.F. Kaner, F. Beyer, H.O. Dickinson, E. Pienaar, F. Campbell, and C. Schlesinger Effectiveness of brief alcohol interventions in primary care populations Cochrane Database Syst Rev 2007 CD004148
62. R.C. Kessler, S. Zhao, D.G. Blazer, and M. Swartz Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey J Affect Disord 45 1997 19 30
63. A. Khoruts, L. Stahnke, C.J. McClain, G. Logan, and J.I. Allen Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients Hepatology 13 1991 267 276
64. B.M. Kinsey, D.C. Jackson, and F.M. Orson Anti-drug vaccines to treat substance abuse Immunol Cell Biol 87 2009 309 314
65. B.M. Kinsey, T.R. Kosten, and F.M. Orson Anti-cocaine vaccine development Expert Rev Vaccines 9 2010 1109 1114
66. R.M. Klevens, D.J. Hu, R. Jiles, and S.D. Holmberg Evolving epidemiology of hepatitis C virus in the United States Clin Infect Dis 55 Suppl. 1 2012 S3 S9
67. T. Kosten, C. Domingo, F. Orson, and B. Kinsey Vaccines against stimulants: cocaine and methamphetamine Br J Clin Pharmacol 2013 [Epub ahead of print, PMID: 23509915]
68. S.M. Kousik, T.C. Napier, and P.M. Carvey The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation Front Pharmacol 3 2012 121
69. H.R. Kranzler, and J.R. McKay Personalized treatment of alcohol dependence Curr Psychiatry Rep 14 2012 486 493
70. T.F. Kresina, J. Normand, J. Khalsa, J. Mitty, T. Flanigan, and H. Francis Addressing the need for treatment paradigms for drug-abusing patients with multiple morbidities Clin Infect Dis 38 Suppl. 5 2004 S398 S401
71. E. Krupitsky, E. Zvartau, E. Blokhina, E. Verbitskaya, V. Wahlgren, and M. Tsoy-Podosenin Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence Arch Gen Psychiatry 69 2012 973 981
72. B.M. Kuehn WHO documents worldwide need for better drug abuse treatment - and access to it JAMA 308 2012 442 443
73. S. Leclercq, P.D. Cani, A.M. Neyrinck, P. Starkel, F. Jamar, and M. Mikolajczak Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects Brain Behav Immun 26 2012 911 918
74. S.L. Letendre, M. Cherner, R.J. Ellis, J. Marquie-Beck, B. Gragg, and T. Marcotte The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease AIDS 19 Suppl. 3 2005 S72 S78
75. H. Liang, X. Wang, H. Chen, L. Song, L. Ye, and S.H. Wang Methamphetamine enhances HIV infection of macrophages Am J Pathol 172 2008 1617 1624
76. R.Z. Litten, M. Egli, M. Heilig, C. Cui, J.B. Fertig, and M.L. Ryan Medications development to treat alcohol dependence: a vision for the next decade Addict Biol 17 2012 513 527
77. L. Liu, J.K. Coller, L.R. Watkins, A.A. Somogyi, and M.R. Hutchinson Naloxone-precipitated morphine withdrawal behavior and brain IL-1beta expression: comparison of different mouse strains Brain Behav Immun 25 2011 1223 1232
78. E. Llorente-Garcia, P. Abreu-Gonzalez, and M.C. Gonzalez-Hernandez Hematological, immunological and neurochemical effects of chronic amphetamine treatment in male rats J Physiol Biochem 65 2009 61 69
79. J.M. Loftis, D. Choi, W. Hoffman, and M.S. Huckans Methamphetamine causes persistent immune dysregulation: a cross-species, translational report Neurotox Res 20 2011 59 68
80. J.M. Loftis, and M. Huckans Cognitive enhancement in combination with 'brain repair' may be optimal for the treatment of stimulant addiction Addiction 106 2011 1021 1022
81. J.M. Loftis, M. Huckans, S. Ruimy, D.J. Hinrichs, and P. Hauser Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha Neurosci Lett 430 2008 264 268
82. J.M. Loftis, A.M. Matthews, and P. Hauser Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management Drugs 66 2006 155 174
83. J.M. Loftis, C.J. Wilhelm, A.A. Vandenbark, and M. Huckans Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction PLoS One 8 2013 e56306
84. D.E. Logan, and G.A. Marlatt Harm reduction therapy: a practice-friendly review of research J Clin Psychol 66 2010 201 214
85. J. Ma, J. Wang, J. Wan, R. Charboneau, Y. Chang, and R.A. Barke Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection Infect Immun 78 2010 830 837
86. R.R. MacGregor Alcohol and immune defense JAMA 256 1986 1474 1479
87. R.R. MacGregor, S.J. Gluckman, and J.R. Senior Granulocyte function and levels of immunoglobulins and complement in patients admitted for withdrawal from alcohol J Infect Dis 138 1978 747 755
88. P. Mandrekar, G. Bellerose, and G. Szabo Inhibition of NF-kappa B binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human monocytes Alcohol Clin Exp Res 26 2002 1872 1879
89. K. Mann, and D. Hermann Individualised treatment in alcohol-dependent patients Eur Arch Psychiatry Clin Neurosci 260 Suppl. 2 2010 S116 S120
90. G.A. Marlatt, and K. Witkiewitz Update on harm-reduction policy and intervention research Annu Rev Clin Psychol 6 2010 591 606
91. M.P. McGovern, H. Xie, S.R. Segal, L. Siembab, and R.E. Drake Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers J Subst Abuse Treat 31 2006 267 275
92. A.T. McLellan, D.C. Lewis, C.P. O'Brien, and H.D. Kleber Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation JAMA 284 2000 1689 1695
93. G. Miller Psychopharmacology. Tackling alcoholism with drugs Science 320 2008 168 170
94. H. Mizoguchi, K. Takuma, A. Fukakusa, Y. Ito, A. Nakatani, and D. Ibi Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice Psychopharmacology (Berl) 196 2008 233 241
95. L.J. Mooney, S. Nielsen, A. Saxon, M. Hillhouse, C. Thomas, and A. Hasson Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology Contemp Clin Trials 34 2013 196 204
96. B.N. Mukunda, J.M. Callahan, M.S. Hobbs, and B.C. West Cocaine inhibits human neutrophil phagocytosis and phagolysosomal acidification in vitro Immunopharmacol Immunotoxicol 22 2000 373 386
97. National Institute on Drug Abuse (NIDA) http://www.drugabuse.gov/about- nida
98. A.H. Newman, B.L. Blaylock, M.A. Nader, J. Bergman, D.R. Sibley, and P. Skolnick Medication discovery for addiction: translating the dopamine D3 receptor hypothesis Biochem Pharmacol 84 2012 882 890
99. C. Nicolaou, S. Chatzipanagiotou, D. Tzivos, E.O. Tzavellas, F. Boufidou, and I.A. Liappas Serum cytokine concentrations in alcohol-dependent individuals without liver disease Alcohol 32 2004 243 247
100. J. Ninkovic, and S. Roy Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1-, and p38 MAPK-dependent mechanisms Am J Pathol 180 2012 1068 1079
101. D.M. Novick, M. Ochshorn, V. Ghali, T.S. Croxson, W.D. Mercer, and N. Chiorazzi Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients J Pharmacol Exp Ther 250 1989 606 610
102. E. Osterndorff-Kahanek, I. Ponomarev, Y.A. Blednov, and R.A. Harris Gene expression in brain and liver produced by three different regimens of alcohol consumption in mice: comparison with immune activation PLoS One 8 3 2013 e59870
103. A. Parlesak, C. Schafer, S.B. Paulus, S. Hammes, J.P. Diedrich, and C. Bode Phagocytosis and production of reactive oxygen species by peripheral blood phagocytes in patients with different stages of alcohol-induced liver disease: effect of acute exposure to low ethanol concentrations Alcohol Clin Exp Res 27 2003 503 508
104. M. Pascual, P. Balino, S. Alfonso-Loeches, C.M. Aragon, and C. Guerri Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage Brain Behav Immun 25 Suppl. 1 2011 S80 S91
105. M. Patel, A. Keshavarzian, V. Kottapalli, B. Badie, D. Winship, and J.Z. Fields Human neutrophil functions are inhibited in vitro by clinically relevant ethanol concentrations Alcohol Clin Exp Res 20 1996 275 283
106. P. Patrignani, S. Tacconelli, A. Bruno, C. Sostres, and A. Lanas Managing the adverse effects of nonsteroidal anti-inflammatory drugs Expert Rev Clin Pharmacol 4 2011 605 621
107. T. Pellegrino, and B.M. Bayer In vivo effects of cocaine on immune cell function J Neuroimmunol 83 1998 139 147
108. E.C. Penick, B.J. Powell, E.J. Nickel, S.F. Bingham, K.R. Riesenmy, and M.R. Read Co-morbidity of lifetime psychiatric disorder among male alcoholic patients Alcohol Clin Exp Res 18 1994 1289 1293
109. H.M. Pettinati, C.P. O'Brien, and W.D. Dundon Current status of co-occurring mood and substance use disorders: a new therapeutic target Am J Psychiatry 170 2013 23 30
110. R.T. Rahim, M.W. Adler, J.J. Meissler Jr., A. Cowan, T.J. Rogers, and E.B. Geller Abrupt or precipitated withdrawal from morphine induces immunosuppression J Neuroimmunol 127 2002 88 95
111. T. Ramirez, L. Longato, M. Dostalek, M. Tong, J.R. Wands, and S.M. de la Monte Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis Alcohol Alcohol 48 2013 39 52
112. L. Redwine, J. Dang, M. Hall, and M. Irwin Disordered sleep, nocturnal cytokines, and immunity in alcoholics Psychosom Med 65 2003 75 85
113. D.A. Regier, M.E. Farmer, D.S. Rae, B.Z. Locke, S.J. Keith, and L.L. Judd Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study JAMA 264 1990 2511 2518
114. J.L. Rendon, B.A. Janda, M.E. Bianco, and M.A. Choudhry Ethanol exposure suppresses bone marrow-derived dendritic cell inflammatory responses independent of TLR4 expression J Interferon Cytokine Res 32 2012 416 425
115. G.L. Riss, D.I. Chang, C. Wevers, A.M. Westendorf, J. Buer, and N. Scherbaum Opioid maintenance therapy restores CD4+ T cell function by normalizing CD4 + CD25(high) regulatory T cell frequencies in heroin user Brain Behav Immun 26 2012 972 978
116. S. Sakaue, M. Sunagawa, H. Tanigawa, Y. Saito, S.Y. Guo, and M. Okada A single administration of morphine suppresses the reduction of the systemic immune activity caused by acute inflammatory pain in rats Masui 60 2011 336 342
117. J. Savitz, M.B. Frank, T. Victor, M. Bebak, J.H. Marino, and P.S. Bellgowan Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities Brain Behav Immun 2012, Oct 12 [Epub ahead of print, PubMed PMID: 23064081]
118. S.J. Schleifer Psychoneuroimmunologic aspects of alcohol and substance abuse 4th ed. Psychoneuroimmunology vol. 1 2007 549 561
119. S.J. Schleifer, S.E. Keller, and S. Czaja Major depression and immunity in alcohol-dependent persons Brain Behav Immun 20 2006 80 91
120. S.J. Schleifer, S.E. Keller, S. Shiflett, T. Benton, and H. Eckholdt Immune changes in alcohol-dependent patients without medical disorders Alcohol Clin Exp Res 23 1999 1199 1206
121. J.M. Schwarz, M.R. Hutchinson, and S.D. Bilbo Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression J Neurosci 31 49 2011 17835 17847
122. Y. Sekine, Y. Ouchi, G. Sugihara, N. Takei, E. Yoshikawa, and K. Nakamura Methamphetamine causes microglial activation in the brains of human abusers J Neurosci 28 2008 5756 5761
123. A. Shah, P.S. Silverstein, D.P. Singh, and A. Kumar Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-kappaB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes J Neuroinflammation 9 2012 52
124. X.Y. Shen, F.M. Orson, and T.R. Kosten Vaccines against drug abuse Clin Pharmacol Ther 91 2012 60 70
125. S. Sinha, S. Subramanian, T.M. Proctor, L.J. Kaler, and M. Grafe A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS J Neurosci 27 2007 12531 12539
126. S.E. Snider, S.A. Vunck, E.J. van den Oord, D.E. Adkins, J.L. McClay, and P.M. Beardsley The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice Eur J Pharmacol 679 2012 75 80
127. M. Sofuoglu Cognitive enhancement as a pharmacotherapy target for stimulant addiction Addiction 105 2010 38 48
128. J.R. Stevenson, J.P. Schroeder, K. Nixon, J. Besheer, F.T. Crews, and C.W. Hodge Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice Neuropsychopharmacology 34 2009 1209 1222
129. S. Subramanian, B. Zhang, Y. Kosaka, G.G. Burrows, and M.R. Grafe Recombinant T cell receptor ligand treats experimental stroke Stroke 40 2009 2539 2545
130. Substance Abuse & Mental Health Services Administration (SAMHSA) Department of Health and Human Services Federal Register Rules and Regulations 77 235 2012 72752 72761 From the Federal Register Online via the Government Printing Office (http://www.gpo.gov); Doc No: 2012-29417
131. G. Szabo, P. Mandrekar, J. Petrasek, and D. Catalano The unfolding web of innate immune dysregulation in alcoholic liver injury Alcohol Clin Exp Res 35 2011 782 786
132. Z. Talloczy, J. Martinez, D. Joset, Y. Ray, A. Gacser, and S. Toussi Methamphetamine inhibits antigen processing, presentation, and phagocytosis PLoS Pathog 4 2008 e28
133. D.M. Thomas, P.D. Walker, J.A. Benjamins, T.J. Geddes, and D.M. Kuhn Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation J Pharmacol Exp Ther 311 2004 1 7
134. J. Tiihonen, E. Krupitsky, E. Verbitskaya, E. Blokhina, O. Mamontova, and J. Fohr Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial Am J Psychiatry 169 2012 531 536
135. G. Torres, and C. Rivier Differential effects of intermittent or continuous exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression Brain Res 571 1992 204 211
136. R. Vallejo, O. de Leon-Casasola, and R. Benyamin Opioid therapy and immunosuppression: a review Am J Ther 11 2004 354 365
137. A.A. Vandenbark, C. Rich, J. Mooney, A. Zamora, and C. Wang Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice J Immunol 171 2003 127 133
138. N.D. Volkow Substance use disorders in schizophrenia - clinical implications of comorbidity Schizophr Bull 35 2009 469 472
139. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, D. Franceschi, and M. Sedler Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence J Neurosci 21 2001 9414 9418
140. S.L. Walsh, M. Heilig, P.A. Nuzzo, P. Henderson, and M.R. Lofwall Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers Addict Biol 18 2 2013 332 343
141. C. Wang, B.G. Gold, L.J. Kaler, X. Yu, M.E. Afentoulis, and G.G. Burrows Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE J Neurochem 98 2006 1817 1827
142. B. Watzl, and R.R. Watson Role of nutrients in alcohol-induced immunomodulation Alcohol Alcohol 28 1993 89 95
143. R.J. Weber, R. Gomez-Flores, J.E. Smith, and T.J. Martin Immune, neuroendocrine, and somatic alterations in animal models of human heroin abuse J Neuroimmunol 147 2004 134 137
144. R.J. Weber, and A. Pert The periaqueductal gray matter mediates opiate-induced immunosuppression Science 245 1989 188 190
145. S. Wee, L.F. Vendruscolo, K.K. Misra, J.E. Schlosburg, and G.F. Koob A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence Sci Transl Med 4 2012 146ra110
146. E.P. Whitlock, M.R. Polen, C.A. Green, T. Orleans, and J. Klein Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 140 2004 557 568
147. World Health Organization Global Status Report on Alcohol 2004 (Geneva) 2004
148. D. Wrona, L. Sukiennik, M.K. Jurkowski, E. Jurkowlaniec, W. Glac, and J. Tokarski Effects of amphetamine on NK-related cytotoxicity in rats differing in locomotor reactivity and social position Brain Behav Immun 19 2005 69 77
149. Y. Wu, E.L. Lousberg, L.M. Moldenhauer, J.D. Hayball, S.A. Robertson, J.K. Coller, L.R. Watkins, A.A. Somogyi, and M.R. Hutchinson Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment Brain Behav Immun 25 Suppl. 1 2011 S155 S164
150. J. Wybran, T. Appelboom, J.P. Famaey, and A. Govaerts Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes J Immunol 123 1979 1068 1070
151. E. Wypasek, J. Natorska, A.I. Mazur, and E. Kolaczkowska Toll-like receptors expression and NF-kappaB activation in peritoneal leukocytes in morphine-mediated impairment of zymosan-induced peritonitis in swiss mice Arch Immunol Ther Exp (Warsz) 60 2012 373 382
152. B.K. Yamamoto, and J. Raudensky The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse J Neuroimmune Pharmacol 3 2008 203 217
153. H. Yao, K. Kim, M. Duan, T. Hayashi, M. Guo, and S. Morgello Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS J Neurosci 31 2011 5942 5955
154. L. Ye, J.S. Peng, X. Wang, Y.J. Wang, G.X. Luo, and W.Z. Ho Methamphetamine enhances Hepatitis C virus replication in human hepatocytes J Viral Hepat 15 2008 261 270
155. X.Q. Zhang, Y. Cui, Y. Cui, Y. Chen, X.D. Na, F.Y. Chen, X.H. Wei, Y.Y. Li, X.G. Liu, and W.J. Xin Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference Brain Behav Immun 26 2 2012 318 325
156. A. Zgierska, D. Rabago, N. Chawla, K. Kushner, R. Koehler, and A. Marlatt Mindfulness meditation for substance use disorders: a systematic review Subst Abus 30 2009 266 294
157. L. Zhang, K. Kitaichi, Y. Fujimoto, H. Nakayama, E. Shimizu, and M. Iyo Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine Prog Neuropsychopharmacol Biol Psychiatry 30 2006 1381 1393
158. Y.N. Zhao, F. Wang, Y.X. Fan, G.F. Ping, J.Y. Yang, and C.F. Wu Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure Behav Brain Res 236 2013 270 282
159. J.Y. Zhou, Z.A. Jiang, C.Y. Zhao, Z. Zhen, W. Wang, and A.A. Nanji Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver Alcohol Clin Exp Res 37 2013 213 222
160. E.P. Zorrilla, L. Luborsky, J.R. McKay, R. Rosenthal, A. Houldin, and A. Tax The relationship of depression and stressors to immunological assays: a meta-analytic review Brain Behav Immun 15 2001 199 226